Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Current Deferred Revenue (2019 - 2026)

Immatics (IMTX) posted Current Deferred Revenue of $21.6 million for Q4 2025, down 27.78% sequentially from $29.9 million in Q3 2025, and down 43.75% YoY from $38.4 million in Q4 2024.

Analysis

Immatics (IMTX) Current Deferred Revenue (2019 - 2026) Analysis & Trends

Immatics has reported Current Deferred Revenue for 7 years, with the latest figure at $21.6 million in Q4 2025.

  • Quarterly Current Deferred Revenue fell 43.75% year-over-year to $21.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.6 million (down 43.75% YoY) and the FY2025 annual result came in at $20.9 million, down 46.1% from the prior year.
  • Current Deferred Revenue declined to $21.6 million in Q4 2025 per IMTX's latest filing, from $29.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $124.3 million in Q4 2023 and troughed at $21.6 million in Q4 2025.
  • A 5-year average of $72.9 million and a median of $73.5 million in 2021 frame the typical range for Current Deferred Revenue.
  • The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue soared 87.56% in 2023, then slumped 70.74% in 2025.
  • Over 5 years, Current Deferred Revenue stood at $112.8 million in 2021, then plunged by 41.26% to $66.3 million in 2022, then jumped by 87.56% to $124.3 million in 2023, then slumped by 69.13% to $38.4 million in 2024, then slumped by 43.75% to $21.6 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $21.6 million, $29.9 million, and $31.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.12 Mn
Mar 31, 2026 15.48 Mn
Dec 31, 2025 18.41 Mn
Sep 30, 2025 29.88 Mn
Jun 30, 2025 27.61 Mn
Mar 31, 2025 26.61 Mn
Dec 31, 2024 38.37 Mn
Sep 30, 2024 75.70 Mn
Jun 30, 2024 102.87 Mn
Mar 31, 2024 104.86 Mn
Dec 31, 2023 108.03 Mn
Sep 30, 2023 67.55 Mn
Jun 30, 2023 74.04 Mn
Mar 31, 2023 69.52 Mn
Dec 31, 2022 66.27 Mn
Sep 30, 2022 80.81 Mn
Jun 30, 2022 83.65 Mn
Mar 31, 2022 68.96 Mn
Dec 31, 2021 57.66 Mn
Sep 30, 2021 72.97 Mn